The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal decongestant."

Summary

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.

The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.

The public comment period ends on May 7, after which the FDA may finalize the ban.

  • TrippaSnippa@lemm.ee
    1·
    6 days ago

    It’s the same here. The Therapeutic Goods Administration, our equivalent to the FDA, generally follows along with FDA regulations (though I don’t think that will continue from next year somehow).

    • Mercuri@lemmy.world
      2·
      5 days ago

      (though I don’t think that will continue from next year somehow).

      Yeah, might be hard to follow FDA regulations when the FDA gets dismantled and no longer exists… eye twitch